MARKET

AUPH

AUPH

Aurinia Pharmace
NASDAQ
14.30
-0.30
-2.05%
Opening 13:32 03/27 EDT
OPEN
14.53
PREV CLOSE
14.60
HIGH
14.53
LOW
14.11
VOLUME
502.15K
TURNOVER
--
52 WEEK HIGH
16.54
52 WEEK LOW
6.83
MARKET CAP
1.90B
P/E (TTM)
6.91
1D
5D
1M
3M
1Y
5Y
1D
Aurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
TipRanks · 4d ago
MKT Capital ‘applauds’ Aurinia’s management transition
TipRanks · 4d ago
Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning
Benzinga · 4d ago
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
TipRanks · 4d ago
Aurinia Names Board Chair Kevin Tang New CEO, Overhauls Executive Team
Dow Jones · 4d ago
Aurinia Pharmaceuticals appoints Kevin Tang as CEO
Seeking Alpha · 4d ago
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
TipRanks · 4d ago
Aurinia names Kevin Tang CEO, appoints Ryan Cole COO
Reuters · 4d ago
More
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.

Webull offers Aurinia Pharmaceuticals Inc stock information, including NASDAQ: AUPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AUPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AUPH stock methods without spending real money on the virtual paper trading platform.